Objectives:

  1. Discuss the rationale for perioperative immunotherapy in multiple cancer types.
  2. Discuss the considerations that guide timing of surgery following checkpoint blockade.
  3. Identify common toxicities of checkpoint blockade, especially those relevant to surgeons.
Session date: 
02/21/2024 - 7:20am to 8:20am CST
Location: 
Virtual/ HSLC 1335
United States
  • 1.00 AAPA Category 1 CME
  • 1.00 ABS Accredited CME
    • 1.00 ABS Self-Assessment
  • 1.00 MOC: ABS Lifelong Learning & Self-Assessment Points (Part II)
    This activity meets the ABS requirements for CME and self‐assessment credit toward Part 2 of the ABS MOC program.
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report
Presenter(s): 
Taylor Aiken, MD